Free Trial

Sagimet Biosciences (SGMT) Insider Trading & Ownership

Sagimet Biosciences logo
$4.95 -0.12 (-2.37%)
(As of 12/20/2024 05:31 PM ET)

Sagimet Biosciences (NASDAQ:SGMT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.60%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$63,767.00
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$178,223.55
Get SGMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SGMT Insider Buying and Selling by Quarter

Sagimet Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/23/2024George KembleChairmanSell23,625$3.17$74,891.25  
7/19/2024Eduardo Bruno MartinsInsiderSell8,357$3.10$25,906.70  
7/19/2024Elizabeth RozekGeneral CounselSell10,914$3.10$33,833.40  
7/19/2024George KembleChairmanSell14,062$3.10$43,592.20  
3/26/2024David HappelCEOBuy12,100$5.27$63,767.00  
(Data available from 1/1/2013 forward)

SGMT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sagimet Biosciences includes Beth C Seidenberg, David Happel, Eduardo Bruno Martins, Elizabeth Rozek, Enterprise Associates 13 L New, and George Kemble. Learn more on insiders at SGMT.

17.60% of Sagimet Biosciences stock is owned by insiders. Learn more on SGMT's insider holdings.

The following insiders have purchased SGMT shares in the last 24 months: Beth C Seidenberg ($750,000.00), David Happel ($65,153.50), and Enterprise Associates 13 L New ($480,000.00).

Insiders have purchased a total of 89,565 SGMT shares in the last 24 months for a total of $1,295,153.50 bought.

The following insiders have sold SGMT shares in the last 24 months: Eduardo Bruno Martins ($25,906.70), Elizabeth Rozek ($33,833.40), and George Kemble ($118,483.45).

Insiders have sold a total of 56,958 Sagimet Biosciences shares in the last 24 months for a total of $178,223.55 sold.

Sagimet Biosciences Key Executives

  • Dr. George W. Kemble Ph.D. (Age 62)
    Executive Chairman of the Board
    Compensation: $484k
  • Mr. David A. Happel (Age 62)
    CEO, President & Director
    Compensation: $836.18k
  • Dr. Eduardo Bruno Martins DPhil (Age 61)
    M.D., Ph.D., Chief Medical Officer
    Compensation: $649.33k
  • Mr. Urs Greber Ph.D.
    Co-Founder
  • Dr. Lucas Pelkmans Ph.D.
    Co-Founder
  • Mr. Thierry Chauche (Age 48)
    CFO & Principal Accounting Officer
  • Ms. Elizabeth Rozek Esq. (Age 52)
    J.D., General Counsel & Chief Compliance Officer
    1 recent trades
  • Dr. Marie O'Farrell Ph.D.
    Senior Vice President of Research & Development


This page (NASDAQ:SGMT) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners